AKT and p21WAF1/CIP1 as potential genistein targets in BRCA1-mutant human breast cancer cell lines

Anticancer Research

Volumn 30, Issue 6, 2010, Pages 2049-2054

  Privat, Maud ^a,b   Aubel, Corinne ^a,b   Arnould, Stephanie ^a,b   Communal, Yves ^a   Ferrara, Marc ^b,c   Bignon, Yves Jean ^a,b  

^a CENTRE JEAN PERRIN   (France)

^b UNIVERSITÉ CLERMONT AUVERGNE   (France)

^c CRNH AUVERGNE   (France)

Author keywords

AKT; BRCA1; Breast cancer; Genistein; p21WAF1 CIP1

Indexed keywords

BRCA1 PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1; GENISTEIN; PROTEIN KINASE B; PROTEIN P21; PROTEIN P21 WAF1 CIP1; RNA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL PROLIFERATION; DRUG CYTOTOXICITY; DRUG MECHANISM; DRUG RESPONSE; DRUG SENSITIVITY; DRUG TARGETING; GENE EXPRESSION REGULATION; GENE MUTATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; WESTERN BLOTTING;

ANTICARCINOGENIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P21; FEMALE; GENES, BRCA1; GENISTEIN; HUMANS; MUTATION; PROTO-ONCOGENE PROTEINS C-AKT; RNA, MESSENGER;

EID: 77955059166     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55(2): 74-108, 2005.
2. Lee HP, Gourley L, Duffy SW, Esteve J, Lee J and Day NE: Dietary effects on breast-cancer risk in Singapore. Lancet 337(8751): 1197-200, 1991.
3. Dai Q, Shu XO, Jin F et al: Population-based case-control study of soyfood intake and breast cancer risk in Shanghai. Br J Cancer 85(3): 372-378, 2001. (Pubitemid 32747705)
4. Magee PJ and Rowland IR: Phyto-oestrogens, their mechanism of action: current evidence for a role in breast and prostate cancer. Br J Nutr 91(4): 513-531, 2004.
5. Lamartiniere CA: Protection against breast cancer with genistein: a component of soy. Am J Clin Nutr 71(6 Suppl): 1705S-1707S; discussion 1708S-1709S, 2000.
6. Fan S, Meng Q, Auborn K, Carter T and Rosen EM: BRCA1 and BRCA2 as molecular targets for phytochemicals indole-3-carbinol and genistein in breast and prostate cancer cells. Br J Cancer 94(3): 407-426, 2006.
7. Bernard-Gallon DJ, Maurizis JC, Rio PG and Bignon YJ: Influence of genistein and daidzein on BRCA1 protein levels in human breast cell lines. J Natl Cancer Inst 90(11): 862-863, 1998.
8. Narod SA and Foulkes WD: BRCA1 and BRCA2: 1994 and beyond. Nat Rev Cancer 4(9): 665-676, 2004.
9. Revillion F, Charlier M, Lhotellier V et al: Messenger RNA expression of leptin and leptin receptors and their prognostic value in 322 human primary breast cancers. Clin Cancer Res 12(7 Pt 1): 2088-2094, 2006.
10. Elstrodt F, Hollestelle A, Nagel JH et al: BRCA1 mutation analysis of 41 human breast cancer cell lines reveals three new deleterious mutants. Cancer Res 66(1): 41-45, 2006.
11. Williamson G and Manach C: Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. Am J Clin Nutr 81(1 Suppl): 243S-255S, 2005.
12. Setchell KD: Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. Am J Clin Nutr 68(6 Suppl): 1333S-1346S, 1998.
13. Mathey J, Lamothe V, Coxam V, Potier M, Sauvant P and Pelissero CB: Concentrations of isoflavones in plasma and urine of post-menopausal women chronically ingesting high quantities of soy isoflavones. J Pharmaceut and Biomed Anal 41(3): 957-965, 2006.
14. Caetano B, Le Corre L, Chalabi N, Delort L, Bignon YJ and Bernard-Gallon DJ: Soya phytonutrients act on a panel of genes implicated with BRCA1 and BRCA2 oncosuppressors in human breast cell lines. Br J Nutr 95(2): 406-413, 2006.
15. Li Y, Upadhyay S, Bhuiyan M and Sarkar FH: Induction of apoptosis in breast cancer cells MDA-MB-231 by genistein. Oncogene 18(20): 3166-3172, 1999. (Pubitemid 29261238)
16. Ise R, Han D, Takahashi Y et al: Expression profiling of the estrogen responsive genes in response to phytoestrogens using a customized DNA microarray. FEBS Lett 579(7): 1732-1740, 2005.
17. 2/M cell cycle arrest is associated with MDC1 up-regulation and PLK1 down-regulation. Eur J Pharmacol 575(1-3): 12-20, 2007.
18. Bai J, Sata N, Nagai H et al: Genistein-induced changes in gene expression in Panc 1 cells at physiological concentrations of genistein. Pancreas 29(2): 93-98, 2004.
19. Greenbaum D, Colangelo C, Williams K and Gerstein M: Comparing protein abundance and mRNA expression levels on a genomic scale. Genome Biol 4(9): 117, 2003.
20. Privat M, Aubel C, Arnould S, Communal Y, Ferrara M and Bignon YJ: Breast cancer cell response to genistein is conditioned by BRCA1 mutations. Biochem Biophys Res Comm 379(3): 785-789, 2009.
21. Liu S, Bishop WR and Liu M: Differential effects of cell cycle regulatory protein p21(WAF1/Cip1) on apoptosis and sensitivity to cancer chemotherapy. Drug Resist Updat 6(4): 183-195, 2003.
22. Shao ZM, Wu J, Shen ZZ and Barsky SH: Genistein exerts multiple suppressive effects on human breast carcinoma cells. Cancer Res 58(21): 4851-4857, 1998.
23. Song G, Ouyang G and Bao S: The activation of Akt/PKB signaling pathway and cell survival. J Cell Mol Med 9(1): 59-71, 2005.
24. WAF1/CiP1. Nature 389(6647): 187-190, 1997.
25. Lu M and Arrick BA: Transactivation of the p21 promoter by BRCA1 splice variants in mammary epithelial cells: evidence for both common and distinct activities of wild-type and mutant forms. Oncogene 19(54): 6351-6360, 2000.